Skip to main content

Table 3 Haemoglobin concentration, anaemia, and parasitaemia among participants in an antimalarial in vivo efficacy study, Faladje, Mali.

From: Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali

Characteristics

AS+AQ

AS+SP

AQ+SP

Day 0

   

   N

133

132

132

   Mean Haemoglobin ± S.D (g/dl)

9.83 ± 1.8

9.71 ± 1.59

9.98 ± 1.59

   Anaemia (< 11 g/dl), n (%)

93 (69.9)

102 (77.3)

97 (73.5)

Day 14

   

   N

131

130

130

   §Mean Haemoglobin ± S.D (g/dl)

10.17 ± 1.5

9.89 ± 1.40

10.43 ± 1.49

   *Anaemia (< 11 g/dl), n (%)

87 (65.9)

100 (77.5)

81 (61.4)

Day 28

   

   N

105

127

130

   §SMean Haemoglobin ± S.D (g/dl)

10.78 ± 1.49

10.5 ± 1.40

11.05 ± 1.52

   **Anaemia (< 11 g/dl), n (%)

57(54.3)

76 (59.8)

60 (46.2)

Parasitaemia, n (%)

   

   Day2

14(10.5)

14(10.7)

67(50.7)

   Day3

2(1.5)

1(0.8)

8 (6.0)

   Day14

5(3.8)

2(1.6)

2(1.5)

   Day28

31(29.5)

9(7.1)

3(2.3)

  1. AS+AQ, artesunate + amodiaquine; AS+SP, artesunate + sulphadoxine-pyrimethamine; AQ+SP, amodiaquine + sulphadoxine-pyrimethamine
  2. *X 2 test: p = 0.014 overall (2 × 3); p = 0.030, AS+SP vs. AS+AQ; p = 0.0046, AS+SP vs. AQ+SP; p = 0.48, AS+AQ vs. AQ+SP.
  3. **X 2 test: p = 0.08 overall (2 × 3); p = 0.027, AQ+SP vs. AS+SP; p = 0.21, AQ+SP vs. AS+AQ; p = 0.39, AS+AQ vs. AS+SP
  4. §Paired t-test comparison day 0 vs. day 14: overall, p < 0.01; AQ+SP, p = 0.001; AS+AQ, p = 0.011; AS+SP, p = 0.033.
  5. §SPaired t-test comparison day 0 vs. day 28: overall, p < 0.001; AQ+SP, p < 0.001; AS+AQ, p < 0.001; AS+SP, p < 0.001
  6. X 2 test: overall (2 × 3); Time points showing difference among the three groups: Day 2, p < 0.001; Day3, p = 0.017; Day 28, p < 0.001.